${site.data.firmName}${SEMFirmNameAlt}
Practice Areas

Zofran and Xarelto: Drugs in the News

dangerous_drugs.jpgLately Zofran, a drug used to treat morning sickness and Xarelto, a blood thinner have been in the news. If you were taking these drugs and suffered an injury you may have a legal claim.

ZOFRAN AND BIRTH DEFECTS

The safety risks of Zofran are being investigated thoroughly and various agencies are monitoring all developments. Zofran and generfic versions of ondansetron have been approved by the FDA to prevent nausea and vomiting caused by chemotherapy, radiation therapy and surgery. These drugs have never been approved to treat morning sickness at any stage of a pregnancy. If you or a loved one took Zofran for morning sickness during pregnancy and your baby was born with a cleft palate, cleft lip, or congenital heart defect, please call us for a confidential evaluation of your potential claim.

XARELTO AND INTERNAL BLEEDING

Xarelto (rivaroxaban) is an anticoagulant, or blood thinner that prevents the formation of blood clots. Xarelto is a "new generation" anticoagulant, which is used specifically to reduce the risk of blood clots and strokes. Xarelto was additionally marketed as being easier to use than Warfarin, also known as Coumadin, which is an older anticoagulant, because it does not require the same level of medical monitoring.

Xarelto has been linked to incidences of uncontrollable bleeding (hemorrhaging). The "newer generation" blood thinners do not have an antidote. This means that often very minor injuries - including minor cuts or undetectable internal bleeding - can result in uncontrolled bleeding, which can be fatal.

Injuries aleged to be associated with Xarelto include:

  • Stroke
  • Retinal hemorrhages
  • Death
  • Epidural hematoma
  • Intracranial hemorrhages
  • Pulmonary embolism
  • Hemoglobin decrease
  • Gastrointestinal hemorrhages
  • Deep vein thrombosis
  • Adrenal bleeding

If you or a loved one was prescribed Xarelto and have suffered a serious bleeding event or other serious side effect, please call us for a free and confidential legal consultation.

No Comments

Leave a comment
Comment Information

Privacy Policy | Business Development Solutions by FindLaw, a Thomson Reuters business.